Chlordimorine

Chlordimorine

SCHEMBL31122995

Clc1cc(-c2ccccc2)ccc1OCCCN1CCOCC1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.57
▸ KDR P35968 2/20 0.56
▸ KDM4E B2RXH2 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ KMO O15229 2/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ TSHR P16473 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ LTA4H P09960 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HRH2 P25021 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlordimorine SCHEMBL2107476 1.00 USP2 (0.57) USP2KDRKDM4ENPC1RAB9A
SCHEMBL18763453 0.81 ALDH1A1 (0.55) USP2KDRKDM4ENPC1RAB9A
Hydrochloric Acid SCHEMBL11617183 0.81 USP2 (0.64) USP2KDM4ENPC1RAB9AALDH1A1
SCHEMBL11899308 0.80 RAB9A (0.83) USP2NPC1RAB9AALDH1A1LTA4H
SCHEMBL26437648 0.79 ALDH1A1 (0.63) USP2KDRKDM4ENPC1RAB9A
SCHEMBL21730050 0.79 KDM4E (0.55) USP2KDM4ENPC1RAB9AALDH1A1
SCHEMBL25470949 0.79 ALDH1A1 (0.56) KDRKDM4ENPC1RAB9AKMO
SCHEMBL25470960 0.78 ALDH1A1 (0.61) USP2KDRKDM4ENPC1RAB9A
SCHEMBL4857927 0.78 USP2 (0.88) USP2KDM4EALDH1A1HTTMEN1
SCHEMBL21795448 0.77 KDM4E (0.56) USP2KDM4ENPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025129358-A1 STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES INTELGENX CORP. (CA) 2025-06-26 — — WO disclosed
US-20240327323-A1 Methods of Treating of Halogen- Containing Waste Plastic to Produce Halogenated Products U. S. DEPARTMENT OF ENERGY 2024-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327323-A1 Methods of Treating of Halogen- Containing Waste Plastic to Produce Halogenated Products VCL, SLC6A12, TPO USP2 663/4885KDR 3743/4885KDM4E 2462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback